Literature DB >> 33619052

Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation.

Kensuke Sasaki1, Andrew S Terker1, Yu Pan1, Zhilian Li1, Shirong Cao1, Yinqiu Wang1, Aolei Niu1, Suwan Wang1, Xiaofeng Fan1, Ming-Zhi Zhang2,3, Raymond C Harris2,4,3,5.   

Abstract

BACKGROUND: AKI is characterized by abrupt and reversible kidney dysfunction, and incomplete recovery leads to chronic kidney injury. Previous studies by us and others have indicated that macrophage infiltration and polarization play key roles in recovery from AKI. The role in AKI recovery played by IFN regulatory factor 4 (IRF4), a mediator of polarization of macrophages to the M2 phenotype, is unclear.
METHODS: We used mice with myeloid or macrophage cell-specific deletion of Irf4 (MΦ Irf4 -/- ) to evaluate Irf4's role in renal macrophage polarization and development of fibrosis after severe AKI.
RESULTS: Surprisingly, although macrophage Irf4 deletion had a minimal effect on early renal functional recovery from AKI, it resulted in decreased renal fibrosis 4 weeks after severe AKI, in association with less-activated macrophages. Macrophage Irf4 deletion also protected against renal fibrosis in unilateral ureteral obstruction. Bone marrow-derived monocytes (BMDMs) from MΦ Irf4 -/- mice had diminished chemotactic responses to macrophage chemoattractants, with decreased activation of AKT and PI3 kinase and increased PTEN expression. PI3K and AKT inhibitors markedly decreased chemotaxis in wild-type BMDMs, and in a cultured macrophage cell line. There was significant inhibition of homing of labeled Irf4 -/- BMDMs to postischemic kidneys. Renal macrophage infiltration in response to AKI was markedly decreased in MΦ Irf4 -/- mice or in wild-type mice with inhibition of AKT activity.
CONCLUSIONS: Deletion of Irf4 from myeloid cells protected against development of tubulointerstitial fibrosis after severe ischemic renal injury in mice, due primarily to inhibition of AKT-mediated monocyte recruitment to the injured kidney and reduced activation and subsequent polarization into a profibrotic M2 phenotype.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  acute renal failure; chronic kidney disease; fibrosis; interstitial fibrosis; ischemia-reperfusion; macrophages

Mesh:

Substances:

Year:  2021        PMID: 33619052      PMCID: PMC8259665          DOI: 10.1681/ASN.2020071010

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  48 in total

1.  Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.

Authors:  Ming-Zhi Zhang; Bing Yao; Suwan Wang; Xiaofeng Fan; Guanqing Wu; Haichun Yang; Huiyong Yin; Shilin Yang; Raymond C Harris
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

Review 2.  Molecular biology for formyl peptide receptors in human diseases.

Authors:  Yongsheng Li; Duyun Ye
Journal:  J Mol Med (Berl)       Date:  2013-02-13       Impact factor: 4.599

3.  IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury.

Authors:  Ming-Zhi Zhang; Xin Wang; Yinqiu Wang; Aolei Niu; Suwan Wang; Chenhang Zou; Raymond C Harris
Journal:  Kidney Int       Date:  2016-10-10       Impact factor: 10.612

4.  IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.

Authors:  C-X Wei; H Wong; F Xu; Z Liu; L Ran; R-D Jiang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-12       Impact factor: 3.507

5.  EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast.

Authors:  Yi Cai; Shan-Shan Yu; Ting-Ting Chen; Si Gao; Biao Geng; Yang Yu; Jian-Tao Ye; Pei-Qing Liu
Journal:  Phytomedicine       Date:  2012-11-08       Impact factor: 5.340

6.  Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney.

Authors:  Kazuaki Shimizu; Kengo Furuichi; Norihiko Sakai; Kiyoki Kitagawa; Kouji Matsushima; Naofumi Mukaida; Shuichi Kaneko; Takashi Wada
Journal:  Hypertens Res       Date:  2011-03-31       Impact factor: 3.872

7.  Differential Ly6C Expression after Renal Ischemia-Reperfusion Identifies Unique Macrophage Populations.

Authors:  Meghan Clements; Michael Gershenovich; Christopher Chaber; Juanita Campos-Rivera; Pan Du; Mindy Zhang; Steve Ledbetter; Anna Zuk
Journal:  J Am Soc Nephrol       Date:  2015-05-26       Impact factor: 10.121

8.  CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.

Authors:  Xiaogang Peng; Jing Zhang; Zhicheng Xiao; Yanjun Dong; Jie Du
Journal:  J Immunol       Date:  2015-08-07       Impact factor: 5.422

Review 9.  MAP kinases and cell migration.

Authors:  Cai Huang; Ken Jacobson; Michael D Schaller
Journal:  J Cell Sci       Date:  2004-09-15       Impact factor: 5.285

10.  Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.

Authors:  Elizabeth M Pierce; Kristin Carpenter; Claudia Jakubzick; Steven L Kunkel; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

View more
  11 in total

1.  Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.

Authors:  Yu Pan; Shirong Cao; Andrew S Terker; Jiaqi Tang; Kensuke Sasaki; Yinqiu Wang; Aolei Niu; Wentian Luo; Xiaofeng Fan; Suwan Wang; Matthew H Wilson; Ming-Zhi Zhang; Raymond C Harris
Journal:  Kidney Int       Date:  2021-11-11       Impact factor: 10.612

2.  Authors' Reply.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  J Am Soc Nephrol       Date:  2021-10-05       Impact factor: 10.121

3.  Heterogenous Role of IRF4 in Kidney Fibrosis.

Authors:  Zhenyu Liu; Jingbo Zhang
Journal:  J Am Soc Nephrol       Date:  2021-10-05       Impact factor: 10.121

4.  Transcriptional profile changes after treatment of ischemia reperfusion injury-induced kidney fibrosis with 18β-glycyrrhetinic acid.

Authors:  Yamei Jiang; Chengzhe Cai; Pingbao Zhang; Yongsheng Luo; Jingjing Guo; Jiawei Li; Ruiming Rong; Yi Zhang; Tongyu Zhu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 5.  The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis.

Authors:  James M Luther; Agnes B Fogo
Journal:  Kidney Int Suppl (2011)       Date:  2022-03-18

6.  Long non-coding RNA TUG1 knockdown promotes autophagy and improves acute renal injury in ischemia-reperfusion-treated rats by binding to microRNA-29 to silence PTEN.

Authors:  Zhiquan Xu; Xiaoyan Huang; Qiuyu Lin; Wei Xiang
Journal:  BMC Nephrol       Date:  2021-08-24       Impact factor: 2.388

7.  Macrophage-Specific MCPIP1/Regnase-1 Attenuates Kidney Ischemia-Reperfusion Injury by Shaping the Local Inflammatory Response and Tissue Regeneration.

Authors:  Andrea Ribeiro; Ewelina Dobosz; Moritz Krill; Paulina Köhler; Marta Wadowska; Stefanie Steiger; Christoph Schmaderer; Joanna Koziel; Maciej Lech
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

8.  Effect of Fushengong Decoction on PTEN/PI3K/AKT/NF-κB Pathway in Rats With Chronic Renal Failure via Dual-Dimension Network Pharmacology Strategy.

Authors:  Hongyu Luo; Munan Wang; Ke Xu; Qiyao Peng; Bo Zou; Shi Yin; Chao Yu; Lingyan Ren; Ping Li; Li Tang; Yongbo Peng; Xuekuan Huang
Journal:  Front Pharmacol       Date:  2022-03-15       Impact factor: 5.810

9.  Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis.

Authors:  Kensuke Sasaki; Andrew S Terker; Jiaqi Tang; Shirong Cao; Juan Pablo Arroyo; Aolei Niu; Suwan Wang; Xiaofeng Fan; Yahua Zhang; Stephanie R Bennett; Ming-Zhi Zhang; Raymond C Harris
Journal:  JCI Insight       Date:  2022-02-22

10.  EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance.

Authors:  Shirong Cao; Yu Pan; Jiaqi Tang; Andrew S Terker; Juan Pablo Arroyo Ornelas; Guan-Nan Jin; Yinqiu Wang; Aolei Niu; Xiaofeng Fan; Suwan Wang; Raymond C Harris; Ming-Zhi Zhang
Journal:  Nat Commun       Date:  2022-08-10       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.